HK2 is a glycolytic enzyme that catalyzes the first committed step in glucose metabolism, and its upregulation has been observed in many types of cancer, promoting tumor metastasis and glycolysis as well as being a target of transcription factor in several cancers, which playing direct roles in regulation of the Warburg effect [30–32]. This evidence concerns the gene HK2 and neoplasm.